ManagedCareCGM

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

The Value of Continuous Glucose Monitoring during the COVID-19 Pandemic and New Era of Digital Healthcare

Free On-demand CE Activity:

Intended Audience: This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.

Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

EDUCATIONAL OBJECTIVES

  • Describe the benefits of remote monitoring in the management of hospitalized patients with COVID-19 and dysglycemia
  • Assess the value of rtCGM in improving quality of care and reducing societal health-costs in a new era of digital health
  • Characterize the role of rtCGM as part of an employer-driven diabetes management strategy
  • Identify appropriate benefit design strategies to reduce healthcare system burden and improve quality, clinical, and economic outcomes

EXPERT FACULTY

Daniel DeSalvo, MD
Assistant Professor
Pediatric Endocrinologist
Baylor College of Medicine
Texas Children’s Hospital

Jeffrey Dunn, PharmD, MBA
(Formerly) Vice President, Clinical Strategy and Programs Industry Relations
Magellan Rx Management

Troy Ross, MSM
President & CEO
Mid-America Coalition on Health Care

For complete CE information and to register for this activity, please go to:
https://www.managedcarecgm.com/neweraofcgm/

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.